Japan, May 18 -- MITSUBISHI TANABE PHARMA CORP has got intellectual property rights for 'NOVEL 3,5-DISUBSTITUTED PYRIDINE AND 3,5-DISUBSTITUTED PYRIDAZINE DERIVATIVES AND PHARMACEUTICAL USE OF THE SAME.' Other related details are as follows:

Application Number: JP,2025-106153

Category (FI): C07D401/14,C07D413/04,C07D401/04,C07D237/08,C07D213/65,A61P17/04,A61P13/08,A61P27/06,A61P25/04,A61P1/04,A61P29/00,101,A61P19/02,A61P11/06,A61P1/16,A61P17/00,C07D237/14,A61K31/50,A61K31/4418,A61K31/444,A61K31/4439,A61K31/5377,A61K31/501,A61K31/538,A61K31/4545,A61K31/496,A61P35/00,A61P29/00,A61P27/02,A61P13/00,A61P3/10,A61P3/04,A61P13/12,A61P9/10,A61P11/00,A61K31/4709,C07D413/14,C07D401/12

Stage: Grant (IP right granted following substantive examination...